Patent · US Active

α4β7 thioether peptide dimer antagonists

US10626146B2 · kind B2 · utility

12Cited by

28References

22Claims

0Family size

Assignee

Protagonist Therapeutics, Inc. · US

Inventors

Ashok Bhandari · Pleasanton, US
Dinesh V. Patel · Fremont, US
Genet Zemede · San Jose, US
Brian Troy Frederick · Arlanza, US
Larry C. Mattheakis · Cupertino, US
David Liu · Palo Alto, US

Key dates

Filing date	Jul 19, 2018
Grant date	Apr 21, 2020
Priority date	—
Expiry date	Jul 19, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to thioether monomer and dimer peptide molecules which inhibit binding of α4β7 to the mucosal addressing cell adhesion molecule (MAdCAM) in vivo.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.